Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 6.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.04 | 52 Week High | $45.34 | |||
| Open | $6.04 | 52 Week Low | $15.92 | |||
| Day High | $6.04 | P/E | 2.59 | |||
| Day Low | $6.04 | EPS | $2.33 | |||
| Volume | 5,033 | |||||
